PTC Therapeutics: A Balanced Hold Rating Amid Regulatory Challenges and Upcoming Milestones
TipRanksApr 27 07:55
RBC Capital Sticks to Their Hold Rating for PTC Therapeutics (PTCT)
TipRanksApr 26 18:36
Analysts' Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)
TipRanksApr 26 18:03
Buy Rating Affirmed for PTC Therapeutics Amidst Strong Q1 Performance and Promising Pipeline Prospects
TipRanksApr 26 17:46
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC)
TipRanksApr 26 17:27
Sell Rating on PTC Therapeutics Amid Sustainability Concerns and Market Uncertainties
TipRanksApr 26 14:36
Cantor Fitzgerald, Inc.: The PTC Therapeutics (PTCT.US) rating was reaffirmed, and the target price was 45.00 US dollars.
Zhitong FinanceApr 12 22:01
PTC Therapeutics Analyst Ratings
BenzingaApr 12 21:53
Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), KalVista Pharmaceuticals (KALV) and PTC Therapeutics (PTCT)
TipRanksApr 11 18:00
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Inozyme Pharma (INZY) and PTC Therapeutics (PTCT)
TipRanksApr 9 17:40
Buy Rating for PTC Therapeutics Bolstered by Positive Regulatory Prospects and Gene Therapy Advances
TipRanksMar 19 23:05
PTC Therapeutics Analyst Ratings
BenzingaMar 9 00:33
PTC Therapeutics (PTCT) Receives a Hold From RBC Capital
TipRanksMar 8 20:26
Buy Rating Affirmed for PTC Therapeutics Amid Promising Regulatory Progress and Market Opportunity
TipRanksMar 6 19:16
Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $45 Price Target
BenzingaMar 1 22:40
TD Cowen Maintains Market Perform on PTC Therapeutics, Lowers Price Target to $30
BenzingaMar 1 21:44
PTC Therapeutics Analyst Ratings
BenzingaMar 1 21:43
RBC Raises Price Target on PTC Therapeutics to $28 From $22, Keeps Sector Perform Rating
MT NewswiresMar 1 21:04
Positive Outlook for PTC Therapeutics: A Comprehensive Buy Rating Justification
TipRanksMar 1 20:15
Downgrade to Sell: PTC Therapeutics Faces Significant Commercial and Competitive Challenges
TipRanksMar 1 19:27
No Data
No Data